University of Pittsburgh Heat Shock Protein Modulator Patent for Huntington Disease

USPTO granted patent US12600705B2 to University of Pittsburgh-of the Commonwealth System of Higher Education for heat shock protein modulators comprising thiadiazine compounds. The patent covers compositions for treating heat-shock protein responsive disorders, neurodegenerative conditions including Huntington disease, and cancer. Inventors include Peter Wipf, Linh Khai Ngo, Leila Terrab, and Jeffrey L. Brodsky. Filing date was February 12, 2021.

This patent grant establishes intellectual property protection for the university, creating potential licensing opportunities and exclusivity in the specified therapeutic areas. Pharmaceutical companies and researchers developing treatments for Huntington disease or related neurodegenerative conditions should be aware of this issued patent when planning R&D programs or seeking freedom-to-operate assessments.